111614
论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
- 3.4 Breast Cancer (Dove Med Press)
- 3.2 Clin Epidemiol
- 2.6 Cancer Manag Res
- 2.9 Infect Drug Resist
- 3.7 Clin Interv Aging
- 5.1 Drug Des Dev Ther
- 3.1 Int J Chronic Obstr
- 6.6 Int J Nanomed
- 2.6 Int J Women's Health
- 2.9 Neuropsych Dis Treat
- 2.8 OncoTargets Ther
- 2.0 Patient Prefer Adher
- 2.2 Ther Clin Risk Manag
- 2.5 J Pain Res
- 3.0 Diabet Metab Synd Ob
- 3.2 Psychol Res Behav Ma
- 3.4 Nat Sci Sleep
- 1.8 Pharmgenomics Pers Med
- 2.0 Risk Manag Healthc Policy
- 4.1 J Inflamm Res
- 2.0 Int J Gen Med
- 3.4 J Hepatocell Carcinoma
- 3.0 J Asthma Allergy
- 2.2 Clin Cosmet Investig Dermatol
- 2.4 J Multidiscip Healthc
已发表论文
机器学习衍生的青光眼治疗靶点识别中多种受调控细胞死亡模式
Authors Mou Q, Li G, Xiang S, Zhao Y , Yao K
Received 16 July 2025
Accepted for publication 27 November 2025
Published 4 December 2025 Volume 2025:18 Pages 7255—7270
DOI https://doi.org/10.2147/IJGM.S545553
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Dr Brian C. Gilger
Qianxue Mou,1 Gaigai Li,2 Sifei Xiang,1 Yin Zhao,1 Ke Yao1
1Department of Ophthalmology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, People’s Republic of China; 2Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, People’s Republic of China
Correspondence: Ke Yao, Department of Ophthalmology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, People’s Republic of China, Tel +8618771053657, Email keyao1106@hust.edu.cn
Purpose: Glaucoma is the leading cause of irreversible vision loss worldwide. We aimed to uncover the molecular mechanisms and regulatory networks of hub genes in human glaucoma to identify promising targets for detection and treatment.
Methods: We obtained GSE758, GSE2378, and GSE9944 datasets from the Gene Expression Omnibus database. The list of genes linked to regulated cell death (RCD) was obtained from a previous study. RCD-related differentially expressed genes (DEGs) were identified in patients with glaucoma and controls. Weighted Gene Co-Expression Network Analysis (WGCNA) and machine learning algorithms were used to identify hub genes. Gene set enrichment analysis (GSEA) was used to explore signaling pathways enriched by hub genes, and molecular docking analysis was performed to identify the gene-drug network of hub genes for potential treatment. Immunofluorescence was used to reveal the expression levels of hub genes in glaucomatous mice and controls.
Results: This study identified 358 RCD-related DEGs that distinguished healthy individuals from glaucoma patients and underscored the pivotal involvement of the immune response in human glaucoma pathogenesis. We systematically identified 33 hub genes, including PLEC, DLGAP4, Glycosylphosphatidylinositol (GPI), etc. that demonstrated significant diagnostic or treatment potential for glaucoma. The cytoskeletal regulator PLEC has emerged as a promising candidate gene associated with glaucomatous neurodegeneration with possible acting drugs.
Conclusion: We constructed a machine-learning-driven analytical framework based on diverse RCD patterns to refine molecular subtypes and druggable genes. These findings may provide novel targets for glaucoma detection and treatment.
Keywords: retinal ganglion cell, WGCNA, machine learning, immune cell infiltration
1Department of Ophthalmology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, People’s Republic of China; 2Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, People’s Republic of China
Correspondence: Ke Yao, Department of Ophthalmology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, People’s Republic of China, Tel +8618771053657, Email keyao1106@hust.edu.cn
Purpose: Glaucoma is the leading cause of irreversible vision loss worldwide. We aimed to uncover the molecular mechanisms and regulatory networks of hub genes in human glaucoma to identify promising targets for detection and treatment.
Methods: We obtained GSE758, GSE2378, and GSE9944 datasets from the Gene Expression Omnibus database. The list of genes linked to regulated cell death (RCD) was obtained from a previous study. RCD-related differentially expressed genes (DEGs) were identified in patients with glaucoma and controls. Weighted Gene Co-Expression Network Analysis (WGCNA) and machine learning algorithms were used to identify hub genes. Gene set enrichment analysis (GSEA) was used to explore signaling pathways enriched by hub genes, and molecular docking analysis was performed to identify the gene-drug network of hub genes for potential treatment. Immunofluorescence was used to reveal the expression levels of hub genes in glaucomatous mice and controls.
Results: This study identified 358 RCD-related DEGs that distinguished healthy individuals from glaucoma patients and underscored the pivotal involvement of the immune response in human glaucoma pathogenesis. We systematically identified 33 hub genes, including PLEC, DLGAP4, Glycosylphosphatidylinositol (GPI), etc. that demonstrated significant diagnostic or treatment potential for glaucoma. The cytoskeletal regulator PLEC has emerged as a promising candidate gene associated with glaucomatous neurodegeneration with possible acting drugs.
Conclusion: We constructed a machine-learning-driven analytical framework based on diverse RCD patterns to refine molecular subtypes and druggable genes. These findings may provide novel targets for glaucoma detection and treatment.
Keywords: retinal ganglion cell, WGCNA, machine learning, immune cell infiltration